MJR Webinar
Πηγή: 16ο Συνέδριο ΕΠΕΜΥ, Ιωάννινα, 3-6 Οκτωβρίου 2024
Cardiovascular risk in Rheumatic Diseases
Ι. General Concepts
1. Assessment and management of cardiovascular risk in patients with rheumatoid arthritis
Anyfanti Panagiota, Assistant Professor of Internal Medicine, 2nd Medical Department, Hippokration General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece
2. Cardiovascular Issues in Rheumatic Diseases: Evolving Concepts in Risk Prediction and Rehabilitation
Gasparyan Armen Yuri, MD, PhD, FESC, Associate Professor of Medicine, Departments of Rheumatology and Research and Development, Dudley Group NHS FT, Dudley, UK
3. Cardiovascular disease in Takayasu arteritis and its implications
Misra Dugra Parsana, Professor of Clinical Immunology and Rheumatology, SGPGIMS, Lucknow, India
4. Mental health and loneliness in people with RA
de Thurah Annete, Professor, Department of Clinical Medicine, Aarhus University Hospital, Denmark
5. Social media channels for Rheumatologists with interest in cardiovascular medicine
Gasparyan Armen Yuri, MD, PhD, FESC, Associate Professor of Medicine, Departments of Rheumatology and Research and Development, Dudley Group NHS FT, Dudley, UK
Zimba Olena, Associate Professor of Medicine, Department of Clinical Rheumatology, Immunology and Internal Medicine, University Hospital in Krakow, Poland
ΙΙ. Lifestyle issues and modification A
1. Immunosenescence, adipose tissue, exercise and bed rest
Turner James, PhD, FHEA, Associate Professor, School of Sport, Exercise and Rehabilitation Sciences, University of Birmingham, UK
2. Muscle wasting in RA: chronic gradual reduction, or acute accumulating changes?
Stavropoulos-Kalinoglou Antonios, Associate Professor, Carnegie School of Sport, Leeds Becket University, UK
3. Rheumatoid Arthritis, Cardiovascular Disease and Exercise
Veldhuijzen van Zanten JJ, Professor in Biological Psychology, School of Sport, Exercise and Rehabilitation,University of Birmingham, UK
4. Acute effects of exercise on pain, disease symptoms, and miRNAs in people with RA
Balchin Chris, MD, PhD, Clinical Research Fellow, Guy’s and St Thomas’ NHS Foundation Trust, UK
5. Physical Activity and Rheumatic and Musculoskeltal Diseases (RMDs)
Moe Rikke Helene, PhD, National Resource Centre for Rehabilitation in Rheumatology, Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, and EULAR Representative of Health Professionals in Rheumatology
III. Lifestyle issues and modification B
1. Sedentary behavior and cardiovascular risk in RA
Fenton Sally, Associate Professor in Lifestyle Behavior Change, NIHR Senior Research Fellow, University of Birmingham, UK
2. Interventions to reduce sedentary behaviour in people with RA; A scoping review
Kitas Florentia, BSc, MSc, PhDStudent, University of Birmingham, UK
IV. Disease assessment
1. In the heart of the matter: atherosclerotic cardiovascular disease in RA
Karpouzas George, Clinical Professor of Internal Medicine, UCLA, Los Angeles, CA, USA
2. Importance of accurate measurement of disease activity in the management of RA to prevent cardiovascular damage
van Riel Piet, Professor Emeritus, Radboud University Medical Center, Radboud Institute for Health Sciences, Scientific Institute for Quality of Healthcare, Nijmegen, the Netherlands
3. Linking inflammation and coronary artery disease in patients with RA – Two cardiac cohorts
Enevoldsen Frederic Cosedis, PhD Student, Department of Biomedicine, University of Aarhus, Denmark
4. Cardiology in autoimmune rheumatic diseases – focus on cardiac MRI
Mavrogeni Sofia, MD, PhD, Onassis Cardiac Surgery Center and EKPA, Athens, Greece
5. Microcirculation and the role of capillaroscopy in Rheumatic Diseases
Madenidou Anastasia, Clinical research fellow, University of Manchester, UK